Cargando…
Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression
Glucocorticoids (GCs), mostly dexamethasone (dex), are routinely administered as adjuvant therapy to manage side effects in breast cancer. However, recently, it has been revealed that dex triggers different effects and correlates with opposite outcomes depending on the breast cancer molecular subtyp...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758252/ https://www.ncbi.nlm.nih.gov/pubmed/35761157 http://dx.doi.org/10.1007/s10555-022-10047-1 |